about
sameAs
Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish menLinkage of familial combined hyperlipidaemia to chromosome 1q21-q23Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes.Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.The effectiveness and applicability of different lifestyle interventions for enhancing wellbeing: the study design for a randomized controlled trial for persons with metabolic syndrome risk factors and psychological distress.SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivityFramework of the outreach after a school shooting and the students perceptions of the provided supportIdentification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.Specific collagen XVIII isoforms promote adipose tissue accrual via mechanisms determining adipocyte number and affect fat deposition.Postprandial glucose metabolism and SCFA after consuming wholegrain rye bread and wheat bread enriched with bioprocessed rye bran in individuals with mild gastrointestinal symptoms.Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans.Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis.Response to Brosch et alConjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass.Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish menPersistent organic pollutants and non-alcoholic fatty liver disease in morbidly obese patients: a cohort study.Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism.FADS2 genotype regulates delta-6 desaturase activity and inflammation in human adipose tissueEpigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate LevelsProbiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.Link between GIP and osteopontin in adipose tissue and insulin resistanceDNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk.High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men.Downregulation of CPPED1 expression improves glucose metabolism in vitro in adipocytesThyroid hormone-related regulation of gene expression in human fatty liver.Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.Regulation of alternative splicing in obesity and weight loss.DNA methylation in obesity and type 2 diabetes.Healthy Nordic diet downregulates the expression of genes involved in inflammation in subcutaneous adipose tissue in individuals with features of the metabolic syndrome.Hepatic DPP4 DNA Methylation Associates With Fatty Liver.MFAP5 is related to obesity-associated adipose tissue and extracellular matrix remodeling and inflammation.Interorgan cross talk between fatty acid metabolism, tissue inflammation, and FADS2 genotype in humans with obesity.Epigenetic alterations in blood mirror age-associated DNA methylation and gene expression changes in human liver.Regulation of alternative splicing in human obesity loci.High perceived stress is associated with unfavorable eating behavior in overweight and obese Finns of working age.Comparative nontargeted profiling of metabolic changes in tissues and biofluids in high-fat diet-fed Ossabaw pig.Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis.
P50
Q21133002-294A5098-FFAD-44CA-9E3B-962041F0C52EQ28267263-F86A71A6-F45F-4AF5-83DE-636928A6DC3BQ31100653-742D484A-686F-4E31-B2FA-1689F8BA7483Q33551724-98D89F94-EE38-4DD2-BC54-53B31AF7E423Q33552608-B17B375D-2496-4540-98FF-60806E18FAE7Q33750699-ACC2FAF1-2B66-484D-94D4-EEB99EFE7823Q33846991-F285BEB8-6316-427E-B8B2-A402A1967320Q33882617-741D133C-83E4-4A51-9B90-A4E45F8AFFD3Q34002255-B447776D-5D91-4982-9A54-341B644C20CEQ34505070-FDE15E43-5369-4386-B316-6E3A8D1DDF12Q34565315-2D504A92-3A88-48CF-AA81-EDFA3E94549AQ35015769-FBFE2238-3A15-4719-AFE8-83B0E459BC2AQ35197073-EC9FD115-432E-4E91-B274-BCB58443B46DQ35586589-0FA74341-4F67-43A8-97C0-A1EC73CF67CBQ35591749-EFCD8E5D-EF5F-4E4A-9FDA-C54147C68D37Q36047495-604DAF8A-19D3-4DA5-88C0-DF5B1741CF51Q36105922-2497808E-2EDD-4734-928B-ED0BE502942CQ36339539-5C7FA7B4-0402-43EA-A8BD-8F46894AD4BEQ36399231-DA1D3142-F5CE-4EE0-A4CD-8C3479BB5C17Q36433576-9561A243-BA2F-4583-ACB0-26F3C4F628EAQ36658938-2B6809E6-FD88-436C-BCCC-0DD4F7CD2C34Q36833028-BCA40CCD-96CE-425F-B37D-6389712BFA8CQ36867588-9CE3F079-D3EB-4993-AD16-0A5D3307BAF4Q37082673-6777E113-9E9C-45FC-A305-C6189CFD1FF6Q37178681-C1AEEAA8-56A1-4100-91BE-77C8772D8A8CQ37193261-0442FD32-9E01-4D99-B2D2-10CB50718B36Q37251062-E0340298-BD6E-4048-AD70-571F2C243583Q37341839-B4269C99-B5F1-4E0E-A3AB-D7F7EB025346Q38097859-7F0CB9A5-B65C-4DF8-B918-B120610D33E8Q38132748-BD7C2BD5-8605-4E3F-9D67-25D3418F6728Q38208058-C3750608-6A19-4444-8319-2A7EA09D4F30Q38302092-80DD84A0-6891-4949-9A8E-49B35C83AC86Q38725135-7623C640-1657-4E01-AEAA-03D59DD5B03CQ38866293-040F16BE-879B-4281-B41F-156826E86053Q38987574-DA16CE75-3BA9-4F5C-96E2-D845A502F403Q39136510-4053CD50-A9DA-4180-9607-798EE8854150Q39497666-239FCE2E-C569-4EB0-98FE-905BB87BAE99Q39826925-5F422252-B039-4A91-A8AF-58E6988C2E9DQ40120533-F24B7EF4-6B0E-4682-B9C8-B069E5F39975Q40268832-CD16957C-6ABA-4F46-806B-1BD813FD4DAA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jussi Pihlajamäki
@ast
Jussi Pihlajamäki
@en
Jussi Pihlajamäki
@es
Jussi Pihlajamäki
@nl
Jussi Pihlajamäki
@sl
type
label
Jussi Pihlajamäki
@ast
Jussi Pihlajamäki
@en
Jussi Pihlajamäki
@es
Jussi Pihlajamäki
@nl
Jussi Pihlajamäki
@sl
prefLabel
Jussi Pihlajamäki
@ast
Jussi Pihlajamäki
@en
Jussi Pihlajamäki
@es
Jussi Pihlajamäki
@nl
Jussi Pihlajamäki
@sl
P106
P1153
7003982232
P21
P31
P496
0000-0002-6241-6859
P569
2000-01-01T00:00:00Z